<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00382928</url>
  </required_header>
  <id_info>
    <org_study_id>1216-2004</org_study_id>
    <nct_id>NCT00382928</nct_id>
  </id_info>
  <brief_title>Automatic External Defibrillation Monitoring in Cardiac Arrest</brief_title>
  <official_title>Automatic External Defibrillation Monitoring in Cardiac Arrest</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Atlanta Research and Education Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Atlanta Research and Education Foundation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We propose to randomize automatic external cardioverter/defibrillators (AECD) in patients who
      are at high risk for life-threatening abnormal heart rhythms (arrhythmias) and are admitted
      to the telemetry ward, all other treatments being constant including cardiopulmonary
      resuscitation.

      We hypothesize that the automatic, rapid, accurate and specific diagnostic and therapeutic
      technology used in AECDs will further increase the rate of survival in patients with cardiac
      arrest through rapid and automatic defibrillation, independent of operator initiation, as
      compared to standard cardiopulmonary resuscitation initiated by healthcare providers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiac arrest (CA) is defined as the sudden cessation of effective cardiac pumping function
      as a result of either ventricular asystole (inactivity of the heart) or pulseless ventricular
      tachycardia/ventricular fibrillation (VT/VF). Pulseless ventricular tachycardia/ventricular
      fibrillation is an abnormal electrical activity of the ventricles of the heart. Rapid
      diagnosis and treatment are essential because first, more than a few minutes of total CA
      results in permanent damage to the brain due to lack of oxygen, and second, the success of
      resuscitative measures is related to the rapidity with which they are instituted following
      arrest. For a person in VT/VF the probability of successful defibrillation and subsequent
      survival to hospital discharge is directly and negatively related to the interval between
      onset of VT/VF and delivery of first shock.

      Comparison: By using AECDs we will evaluate if an automatic, rapid, accurate and specific
      diagnostic technology will further increase the rate of survival in patients with VT/VF by
      rapid and automatic defibrillation, independent of operator initiation, as compared to
      standard cardiopulmonary resuscitation (CPR) with conventional defibrillators initiated by
      healthcare providers. This trial will be a randomized, controlled trial and will test if
      AECDs can improve outcome measures when compared to traditional responses.

      Conventional defibrillators are manually operated defibrillators that have to be attached to
      the patient and operated by a healthcare provider or layperson. In contrast, the purpose of
      AECDs is to automatically detect life-threatening arrhythmias and deliver external shocks
      according to a programmable prescription for hospitalized patients, who may be at transient
      risk for the development of life-threatening arrhythmias. AECDs immediately and automatically
      monitor, detect and treat cardiac arrhythmias with no human intervention. The AECD proposed
      to be utilized in this trial, PowerHeart CRM, a product of Cardiac Science, Inc, has been
      evaluated in the hospital setting to assess safety and efficacy, and has been approved by the
      FDA to be prophylactically attached to hospital patients and provide automatic defibrillation
      therapy without human intervention.

      All patients admitted to the telemetry unit will be asked to volunteer for this study. Up to
      3,000 patients will be asked to volunteer in this study during their stay in the telemetry
      unit. This study will evaluate if there is a way to improve survival in CA by comparing two
      groups

      Group 1: This group includes patients admitted to telemetry unit who will undergo standard
      measures of CPR in case cardiac arrest is suspected.

      Group 2: This group includes patients admitted to telemetry unit who will have an AECD
      attached to the chest wall and who will also undergo standard measures of CPR in case of
      cardiac arrest.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2006</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants Without Defibrillation</measure>
    <time_frame>10 minutes</time_frame>
    <description>Time to defibrillation: interval between onset of VT/VF and delivery of first shock. Expected time to defibrillation for AECD group: 30±30 seconds; expected time to defibrillation for Standard of Care group: 180±180.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency of Abnormal Rhythms Monitored by the AECD</measure>
    <time_frame>During the duration of hospital admission on the telemetry ward.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival to Discharge</measure>
    <time_frame>At discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cerebral Performance at Discharge</measure>
    <time_frame>At discharge</time_frame>
    <description>Cerebral Performance Categories/CPC scale:
CPC 1: Good cerebral performance - conscious, alert, able to work, might have mild neurologic or psychological deficit.
CPC 2: Moderate cerebral disability - conscious, sufficient cerebral function for independent activities of daily life. Able to work in sheltered environment.
CPC 3: Severe cerebral disability - conscious, dependent on others for daily support because of impaired brain function. Ranges from ambulatory state to severe dementia or paralysis.
CPC 4: Coma or vegetative state - any degree of coma without the presence of all brain death criteria. Unawareness, even if appears awake (vegetative state) without interaction with environment; may have spontaneous eye opening and sleep/awake cycles. Cerebral unresponsiveness.
CPC 5: Brain death - apnea, areflexia, electroencephalogram (EEG) silence, etc.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">192</enrollment>
  <condition>Death, Sudden, Cardiac</condition>
  <condition>Ventricular Fibrillation</condition>
  <condition>Tachycardia, Ventricular</condition>
  <arm_group>
    <arm_group_label>Standard of Care Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will receive standard of care measures in case of cardiac arrest. They will not receive AECD monitoring or intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AECD Monitoring + Standard of Care Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive AECD monitoring and intervention in addition to standard of care in case of cardiac arrest during admission to the hospital. Defibrillation of pulseless VT/VF by AECD.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Defibrillation of pulseless VT/VF by AECD</intervention_name>
    <description>In case of cardiac arrest caused by shockable rhythms the automatic external cardioverter defibrillator (AECD) will automatically deliver defibrillation. Automated External Cardioverter Defibrillator (AECD; The PowerHeart CRM, Cardiac Science Inc., Seattle, WA) is a device attached to the chest wall by pads, monitors the electrocardiogram, and is capable of automatically delivering electric countershock to appropriate rhythms without operator intervention. The device will deliver only one shock of 150 Joules for pulseless ventricular tachycardia and ventricular fibrillation.</description>
    <arm_group_label>AECD Monitoring + Standard of Care Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients admitted to telemetry ward and emergency department

          -  Age &gt; 18 years.

        Exclusion Criteria:

          -  Pregnant women

          -  Patients with R wave less than 0.5 millivolts.

          -  Patients with functioning Internal Cardiac Device.

          -  Patients with cardiac pacemakers if oversensing by AECD is demonstrated (double
             counting of pacer spikes).

          -  Patients with visible chest lesions that would prevent AECD pad placement.

          -  Patients who are designated Do Not Resuscitate.

          -  Right bundle branch block.

          -  Patients with Parkinson's disease.

          -  Patients with seizure disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>A. Maziar Zafari, M.D., Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Cardiology, Atlanta Veterans Adminstration Medical Center/ Emory University, Decatur, GA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Atlanta Veterans Adminstration Medical Center</name>
      <address>
        <city>Decatur</city>
        <state>Georgia</state>
        <zip>30033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.trialsjournal.com/content/9/1/36</url>
    <description>Click here for detailed information about this study: Automated external cardioversion defibrillation monitoring in cardiac arrest: a randomized trial</description>
  </link>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 29, 2006</study_first_submitted>
  <study_first_submitted_qc>September 29, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 2, 2006</study_first_posted>
  <results_first_submitted>December 12, 2013</results_first_submitted>
  <results_first_submitted_qc>May 29, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 1, 2014</results_first_posted>
  <last_update_submitted>June 22, 2015</last_update_submitted>
  <last_update_submitted_qc>June 22, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 15, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Atlanta VA Medical Center</investigator_affiliation>
    <investigator_full_name>A. Maziar Zafari</investigator_full_name>
    <investigator_title>Chief, Cardiology</investigator_title>
  </responsible_party>
  <keyword>Randomized Controlled Trials</keyword>
  <keyword>Defibrillators</keyword>
  <keyword>Medical Devices</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Ventricular Fibrillation</mesh_term>
    <mesh_term>Death, Sudden</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>One hundred and ninety two patients were recruited in the time period between 10/10/2006 to 7/20/2007 to the telemetry ward of the Atlanta VA Medical Center.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>No Intervention: Standard of Care Group</title>
          <description>Patients will receive standard of care measures in case of cardiac arrest. They will not receive AECD monitoring or intervention</description>
        </group>
        <group group_id="P2">
          <title>Experimental: AECD Monitoring + Standard of Care Group</title>
          <description>Patients will receive AECD monitoring and intervention in addition to standard of care in case of cardiac arrest during admission to the hospital.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="97"/>
                <participants group_id="P2" count="95"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="97"/>
                <participants group_id="P2" count="95"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>No Intervention: Standard of Care Group</title>
          <description>Patients will receive standard of care measures in case of cardiac arrest. They will not receive AECD monitoring or intervention.</description>
        </group>
        <group group_id="B2">
          <title>Experimental: AECD Monitoring + Standard of Care Group</title>
          <description>Patients will receive AECD monitoring and intervention in addition to standard of care in case of cardiac arrest during admission to the hospital.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="97"/>
            <count group_id="B2" value="95"/>
            <count group_id="B3" value="192"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="97"/>
                    <measurement group_id="B2" value="95"/>
                    <measurement group_id="B3" value="192"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62" spread="3.4"/>
                    <measurement group_id="B2" value="61.7" spread="3.4"/>
                    <measurement group_id="B3" value="61.9" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="94"/>
                    <measurement group_id="B2" value="92"/>
                    <measurement group_id="B3" value="186"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Clinical Characteristics of Study Subjects</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>History of Heart Failure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>New Diagnosis of Heart Failure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diabetes mellitus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="46"/>
                    <measurement group_id="B3" value="81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>History of Coronary Artery Disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hypertension</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="74"/>
                    <measurement group_id="B2" value="79"/>
                    <measurement group_id="B3" value="153"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hyperlipidemia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="108"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>EKG on admission</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>normal sinus rhythm</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="81"/>
                    <measurement group_id="B2" value="84"/>
                    <measurement group_id="B3" value="165"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Atrial fibrillation/flutter</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>supraventricular tachycardia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Without Defibrillation</title>
        <description>Time to defibrillation: interval between onset of VT/VF and delivery of first shock. Expected time to defibrillation for AECD group: 30±30 seconds; expected time to defibrillation for Standard of Care group: 180±180.</description>
        <time_frame>10 minutes</time_frame>
        <population>There was only one patient in the Intervention group who received defibrillation.
No patients had CPR or defibrillation in the standard of care group.</population>
        <group_list>
          <group group_id="O1">
            <title>Experimental: AECD Monitoring + Stand of Care Group</title>
            <description>Patients will receive AECD monitoring and intervention in addition to standard of care in case of cardiac arrest during admission to the hospital.</description>
          </group>
          <group group_id="O2">
            <title>No Intervention: Standard of Care Group</title>
            <description>Patients will receive standard of care measures in case of cardiac arrest. They will not receive AECD monitoring or intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Without Defibrillation</title>
          <description>Time to defibrillation: interval between onset of VT/VF and delivery of first shock. Expected time to defibrillation for AECD group: 30±30 seconds; expected time to defibrillation for Standard of Care group: 180±180.</description>
          <population>There was only one patient in the Intervention group who received defibrillation.
No patients had CPR or defibrillation in the standard of care group.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="97"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94" spread="50"/>
                    <measurement group_id="O2" value="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Frequency of Abnormal Rhythms Monitored by the AECD</title>
        <time_frame>During the duration of hospital admission on the telemetry ward.</time_frame>
        <population>Only the AECD+Standard of Care Group was monitored in this portion of the study.</population>
        <group_list>
          <group group_id="O1">
            <title>AECD Monitoring + Standard of Care Group</title>
            <description>Patients will receive AECD monitoring and intervention in addition to standard of care in case of cardiac arrest during admission to the hospital.</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care</title>
            <description>Patients will receive standard of care measures in case of cardiac arrest. They will not receive AECD monitoring or intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Frequency of Abnormal Rhythms Monitored by the AECD</title>
          <population>Only the AECD+Standard of Care Group was monitored in this portion of the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Atrial Fibrillation/Flutter</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Supraventricular Tachycardia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Premature Ventricular Complexes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-Sustained Ventricular Tachycardia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Survival to Discharge</title>
        <time_frame>At discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Experimental: AECD Monitoring + Standard of Care Group</title>
            <description>Patients will receive AECD monitoring and intervention in addition to standard of care in case of cardiac arrest during admission to the hospital.</description>
          </group>
          <group group_id="O2">
            <title>No Intervention: Standard of Care</title>
            <description>Patients will receive standard of care measures in case of cardiac arrest. They will not receive AECD monitoring or intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Survival to Discharge</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="97"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95"/>
                    <measurement group_id="O2" value="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cerebral Performance at Discharge</title>
        <description>Cerebral Performance Categories/CPC scale:
CPC 1: Good cerebral performance – conscious, alert, able to work, might have mild neurologic or psychological deficit.
CPC 2: Moderate cerebral disability – conscious, sufficient cerebral function for independent activities of daily life. Able to work in sheltered environment.
CPC 3: Severe cerebral disability – conscious, dependent on others for daily support because of impaired brain function. Ranges from ambulatory state to severe dementia or paralysis.
CPC 4: Coma or vegetative state – any degree of coma without the presence of all brain death criteria. Unawareness, even if appears awake (vegetative state) without interaction with environment; may have spontaneous eye opening and sleep/awake cycles. Cerebral unresponsiveness.
CPC 5: Brain death – apnea, areflexia, electroencephalogram (EEG) silence, etc.</description>
        <time_frame>At discharge</time_frame>
        <population>Only 1 patient in the Intervention group had defibrillation during hospital admission and his CPC was 1.</population>
        <group_list>
          <group group_id="O1">
            <title>AECD Monitoring + Standard of Care Group</title>
            <description>Patients will receive AECD monitoring and intervention in addition to standard of care in case of cardiac arrest during admission to the hospital.</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care Group</title>
            <description>Patients will receive standard of care measures in case of cardiac arrest. They will not receive AECD monitoring or intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Cerebral Performance at Discharge</title>
          <description>Cerebral Performance Categories/CPC scale:
CPC 1: Good cerebral performance – conscious, alert, able to work, might have mild neurologic or psychological deficit.
CPC 2: Moderate cerebral disability – conscious, sufficient cerebral function for independent activities of daily life. Able to work in sheltered environment.
CPC 3: Severe cerebral disability – conscious, dependent on others for daily support because of impaired brain function. Ranges from ambulatory state to severe dementia or paralysis.
CPC 4: Coma or vegetative state – any degree of coma without the presence of all brain death criteria. Unawareness, even if appears awake (vegetative state) without interaction with environment; may have spontaneous eye opening and sleep/awake cycles. Cerebral unresponsiveness.
CPC 5: Brain death – apnea, areflexia, electroencephalogram (EEG) silence, etc.</description>
          <population>Only 1 patient in the Intervention group had defibrillation during hospital admission and his CPC was 1.</population>
          <units>units on a scale: CPC 1</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Experimental: AECD Monitoring + Standard of Care Group</title>
          <description>Patients will receive AECD monitoring and intervention in addition to standard of care in case of cardiac arrest during admission to the hospital.</description>
        </group>
        <group group_id="E2">
          <title>No Intervention: Standard of Care Group</title>
          <description>Patients will receive standard of care measures in case of cardiac arrest. They will not receive AECD monitoring or intervention.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="97"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="95"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="97"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>False Positive Events in which, the shocks were delivered inappropriately.</sub_title>
                <description>AECD delivered the shock when patient was eating an apple.
Discharge was the result of deliberate action of the patient.</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="95"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="97"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="95"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="97"/>
              </event>
              <event>
                <sub_title>Skin irritation by the pads</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="95"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="97"/>
              </event>
              <event>
                <sub_title>Alarming of the AECD, as the pads detached from the chest wall during sleep</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="95"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="97"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. A. Maziar Zafari</name_or_title>
      <organization>Atlanta Research and Education Foundation</organization>
      <phone>404-321-6111 ext 4019</phone>
      <email>azafari@emory.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

